Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Director | February 08, 2023 | February 10, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 08, 2023 · Filed February 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,008 |
Reported balance
After 2023-02-08 transaction · row 1
1 source rowRow 1 · 2023-02-08 · Grant · Acquired 530 · Balance 51,008 F1: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $138.09 · Expires 2033-02-08 | Direct | 1,790 |
Reported balance
After 2023-02-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-02-08 · Grant · Acquired 1,790 · Balance 1,790 F2: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Options vest 20% Year 1; 40% Year 2; and 40% Year 3
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006027 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006027 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,008 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:13 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,747 | $0.00 Strike: $138.07 | $0.00 |
DisclosureSEC source: 0001140361-22-005098 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,787 Underlying: Common Stock · 1,747 shares Expires 2032-02-11 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:13 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005098 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,478 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,124 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001140361-21-005116 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,040 Underlying: Common Stock · 2,124 shares Expires 2031-02-11 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005116 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,969 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 16:00 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,946 | $0.00 Strike: $111.94 | $0.00 |
DisclosureSEC source: 0001140361-20-003489 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,916 Underlying: Common Stock · 2,946 shares Expires 2030-02-13 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 16:00 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003489 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,379 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 17:40 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,587 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-19-003347 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6.972 Underlying: Common Stock · 3,587 shares Expires 2019-02-13 F2 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 17:40 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003347 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,778 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:05 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,383 | $0.00 Strike: $74.57 | $0.00 |
DisclosureSEC source: 0001140361-18-009156 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,383 Underlying: Common Stock · 3,383 shares Expires 2028-02-15 F2 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:05 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 845 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009156 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,994 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 00:24 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008919 · doc1.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,149 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.